TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7749924
log Bayes Factor = 49.4897
Chromosome 6   position 30,797,991  (GRCh37) Explore rs7749924 on Ensembl!
Variant rs7749924 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.003 0.997
E10-E14 Diabetes mellitus
0.000 0.004 0.996
T36-T50 Poisoning by drugs, medicaments and biological substances
0.996 0.004 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.995 0.005 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.005 0.995
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.981 0.019 0.000
E10.3 With ophthalmic complications
0.000 0.023 0.977
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.976 0.024 0.000
E50-E64 Other nutritional deficiencies
0.000 0.024 0.976
L40.0 Psoriasis vulgaris
0.975 0.025 0.000
T39.1 4-Aminophenol derivatives
0.971 0.029 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.970 0.030 0.000
T43.2 Other and unspecified antidepressants
0.965 0.035 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.965 0.035 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.938 0.062 0.000
E10.5 With peripheral circulatory complications
0.000 0.062 0.938
E10.4 With neurological complications
0.000 0.069 0.931
E55 Vitamin D deficiency
0.000 0.075 0.925
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.907 0.093 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.111 0.889
E53 Deficiency of other B group vitamins
0.000 0.116 0.884
T46 Poisoning by agents primarily affecting the cardiovascular system
0.883 0.117 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.119 0.881
L40.1 Generalised pustular psoriasis
0.870 0.130 0.000
T42.4 Benzodiazepines
0.868 0.132 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.857 0.143 0.000
T43.6 Psychostimulants with abuse potential
0.847 0.153 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.843 0.157 0.000
E06 Thyroiditis
0.000 0.172 0.828
E53.8 Deficiency of other specified B group vitamins
0.000 0.181 0.819
L40.8 Other psoriasis
0.804 0.196 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.804 0.196 0.000
E16 Other disorders of pancreatic internal secretion
0.000 0.201 0.799
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.795 0.205 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.791 0.209 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.784 0.216 0.000
T39.0 Salicylates
0.777 0.223 0.000
E04 Other non-toxic goitre
0.000 0.224 0.776
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.775 0.225 0.000
E10.8 With unspecified complications
0.000 0.228 0.772
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.771 0.229 0.000
E10.2 With renal complications
0.000 0.230 0.770
T36 Poisoning by systemic antibiotics
0.737 0.262 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.735 0.265 0.000
E06.3 Autoimmune thyroiditis
0.000 0.266 0.734
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.733 0.266 0.000
T46.1 Calcium-channel blockers
0.730 0.270 0.000
E16.2 Hypoglycaemia, unspecified
0.000 0.270 0.730
E61 Deficiency of other nutrient elements
0.000 0.271 0.729
E05.8 Other thyrotoxicosis
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
L40.4 Guttate psoriasis
0.717 0.283 0.000
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E10.6 With other specified complications
0.000 0.283 0.717
E10.0 With coma
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.1 Congenital hypothyroidism without goitre
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E10.1 With ketoacidosis
0.000 0.284 0.716
E12 Malnutrition-related diabetes mellitus
0.000 0.286 0.714
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.714 0.286 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.714 0.286 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.714 0.286 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.714 0.286 0.000
T43.9 Psychotropic drug, unspecified
0.713 0.287 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.713 0.287 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.713 0.287 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.295 0.705
T39.4 Antirheumatics, not elsewhere classified
0.703 0.297 0.000
T39.2 Pyrazolone derivatives
0.703 0.297 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.700 0.300 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.700 0.300 0.000
T42.3 Barbiturates
0.700 0.300 0.000
T42.2 Succinimides and oxazolidinediones
0.700 0.300 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.300 0.700
E63 Other nutritional deficiencies
0.000 0.300 0.700
E56 Other vitamin deficiencies
0.000 0.300 0.700
E51 Thiamine deficiency
0.000 0.300 0.700
E50 Vitamin A deficiency
0.000 0.300 0.700
E60 Dietary zinc deficiency
0.000 0.300 0.700
E59 Dietary selenium deficiency
0.000 0.300 0.700
E58 Dietary calcium deficiency
0.000 0.300 0.700
E54 Ascorbic acid deficiency
0.000 0.300 0.700
E52 Niacin deficiency [pellagra]
0.000 0.300 0.700
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.692 0.308 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.692 0.308 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.692 0.308 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.692 0.308 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.692 0.308 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.692 0.308 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.692 0.308 0.000
T44.0 Anticholinesterase agents
0.692 0.308 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.689 0.311 0.000
T42.0 Hydantoin derivatives
0.672 0.328 0.000
E03.8 Other specified hypothyroidism
0.000 0.329 0.671
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.334 0.666
T50.9 Other and unspecified drugs, medicaments and biological substances
0.666 0.334 0.000
E55.0 Rickets, active
0.000 0.336 0.663
T45.0 Antiallergic and antiemetic drugs
0.638 0.362 0.000
E53.9 Vitamin B deficiency, unspecified
0.000 0.366 0.634
E53.1 Pyridoxine deficiency
0.000 0.366 0.634
E53.0 Riboflavin deficiency
0.000 0.366 0.634
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.633 0.367 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.633 0.367 0.000
T46.7 Peripheral vasodilators
0.633 0.367 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.633 0.367 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.633 0.367 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.633 0.367 0.000
E15 Nondiabetic hypoglycaemic coma
0.000 0.368 0.632
T47.1 Other antacids and anti-gastric-secretion drugs
0.632 0.368 0.000
E13 Other specified diabetes mellitus
0.000 0.371 0.629
T42.1 Iminostilbenes
0.622 0.378 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.383 0.617
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.617 0.383 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.387 0.613
E04.0 Non-toxic diffuse goitre
0.000 0.399 0.601
E06.5 Other chronic thyroiditis
0.000 0.406 0.594
E06.4 Drug-induced thyroiditis
0.000 0.406 0.594
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.406 0.594
E06.1 Subacute thyroiditis
0.000 0.406 0.594
E06.0 Acute thyroiditis
0.000 0.406 0.594
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.591 0.409 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.589 0.411 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.579 0.421 0.000
T50.8 Diagnostic agents
0.576 0.424 0.000
T50.7 Analeptics and opioid receptor antagonists
0.576 0.424 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.576 0.424 0.000
T50.5 Appetite depressants
0.576 0.424 0.000
T50.4 Drugs affecting uric acid metabolism
0.576 0.424 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.576 0.424 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.576 0.424 0.000
T50.1 Loop [high-ceiling] diuretics
0.576 0.424 0.000
T50.0 Mineralocorticoids and their antagonists
0.576 0.424 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.427 0.573
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.427 0.573
E16.4 Abnormal secretion of gastrin
0.000 0.427 0.573
E16.3 Increased secretion of glucagon
0.000 0.427 0.573
T43.5 Other and unspecified antipsychotics and neuroleptics
0.566 0.434 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.562 0.438 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.562 0.438 0.000
T47.7 Emetics
0.562 0.438 0.000
T47.6 Antidiarrhoeal drugs
0.562 0.438 0.000
T47.5 Digestants
0.562 0.438 0.000
T47.4 Other laxatives
0.562 0.438 0.000
T47.3 Saline and osmotic laxatives
0.562 0.438 0.000
T47.2 Stimulant laxatives
0.562 0.438 0.000
T47.0 Histamine H(2)-receptor antagonists
0.562 0.438 0.000
E16.1 Other hypoglycaemia
0.000 0.438 0.562
E04.8 Other specified non-toxic goitre
0.000 0.443 0.557
T45.9 Primarily systemic and haematological agent, unspecified
0.555 0.444 0.000
T45.8 Other primarily systemic and haematological agents
0.555 0.444 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.555 0.444 0.000
T45.6 Fibrinolysis-affecting drugs
0.555 0.444 0.000
T45.4 Iron and its compounds
0.555 0.444 0.000
T45.3 Enzymes, not elsewhere classified
0.555 0.444 0.000
T45.2 Vitamins, not elsewhere classified
0.555 0.444 0.000
T38.1 Thyroid hormones and substitutes
0.553 0.446 0.000
E61.1 Iron deficiency
0.000 0.447 0.553
T36.0 Penicillins
0.552 0.448 0.000
E40-E46 Malnutrition
0.000 0.453 0.547
E14 Unspecified diabetes mellitus
0.000 0.458 0.542
T36.9 Systemic antibiotic, unspecified
0.529 0.471 0.000
T36.8 Other systemic antibiotics
0.529 0.471 0.000
T36.7 Antifungal antibiotics, systemically used
0.529 0.471 0.000
T36.6 Rifamycins
0.529 0.471 0.000
T36.5 Aminoglycosides
0.529 0.471 0.000
T36.4 Tetracyclines
0.529 0.471 0.000
T36.3 Macrolides
0.529 0.471 0.000
T36.2 Chloramphenicol group
0.529 0.471 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.529 0.471 0.000
T38.9 Other and unspecified hormone antagonists
0.526 0.474 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.526 0.474 0.000
T38.7 Androgens and anabolic congeners
0.526 0.474 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.526 0.474 0.000
T38.5 Other oestrogens and progestogens
0.526 0.474 0.000
T38.4 Oral contraceptives
0.526 0.474 0.000
T38.2 Antithyroid drugs
0.526 0.474 0.000
T38.0 Glucocorticoids and synthetic analogues
0.526 0.474 0.000
E61.9 Deficiency of nutrient element, unspecified
0.000 0.477 0.523
E61.8 Deficiency of other specified nutrient elements
0.000 0.477 0.523
E61.7 Deficiency of multiple nutrient elements
0.000 0.477 0.523
E61.6 Vanadium deficiency
0.000 0.477 0.523
E61.5 Molybdenum deficiency
0.000 0.477 0.523
E61.4 Chromium deficiency
0.000 0.477 0.523
E61.3 Manganese deficiency
0.000 0.477 0.523
E61.2 Magnesium deficiency
0.000 0.477 0.523
E61.0 Copper deficiency
0.000 0.477 0.523
E06.9 Thyroiditis, unspecified
0.000 0.478 0.522
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.517 0.483 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E12.9 Without complications
0.000 0.488 0.512
E12.8 With unspecified complications
0.000 0.488 0.512
E12.7 With multiple complications
0.000 0.488 0.512
E12.6 With other specified complications
0.000 0.488 0.512
E12.5 With peripheral circulatory complications
0.000 0.488 0.512
E12.4 With neurological complications
0.000 0.488 0.512
E12.3 With ophthalmic complications
0.000 0.488 0.512
E12.2 With renal complications
0.000 0.488 0.512
E12.1 With ketoacidosis
0.000 0.488 0.512
E12.0 With coma
0.000 0.488 0.512
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.512 0.488 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.512 0.488 0.000
T37.5 Antiviral drugs
0.512 0.488 0.000
T37.4 Anthelminthics
0.512 0.488 0.000
T37.3 Other antiprotozoal drugs
0.512 0.488 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.512 0.488 0.000
T37.1 Antimycobacterial drugs
0.512 0.488 0.000
T37.0 Sulphonamides
0.512 0.488 0.000
T41.5 Therapeutic gases
0.512 0.488 0.000
T41.4 Anaesthetic, unspecified
0.512 0.488 0.000
T41.3 Local anaesthetics
0.512 0.488 0.000
T41.2 Other and unspecified general anaesthetics
0.512 0.488 0.000
T41.1 Intravenous anaesthetics
0.512 0.488 0.000
T41.0 Inhaled anaesthetics
0.512 0.488 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.512 0.488 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.512 0.488 0.000
T48.5 Anti-common-cold drugs
0.512 0.488 0.000
T48.4 Expectorants
0.512 0.488 0.000
T48.3 Antitussives
0.512 0.488 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.512 0.488 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.512 0.488 0.000
T48.0 Oxytocic drugs
0.512 0.488 0.000
T49.9 Topical agent, unspecified
0.512 0.488 0.000
T49.8 Other topical agents
0.512 0.488 0.000
T49.7 Dental drugs, topically applied
0.512 0.488 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.512 0.488 0.000
T49.5 Ophthalmological drugs and preparations
0.512 0.488 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.512 0.488 0.000
T49.3 Emollients, demulcents and protectants
0.512 0.488 0.000
T49.2 Local astringents and local detergents
0.512 0.488 0.000
T49.1 Antipruritics
0.512 0.488 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.512 0.488 0.000
E50.9 Vitamin A deficiency, unspecified
0.000 0.498 0.502
E50.8 Other manifestations of vitamin A deficiency
0.000 0.498 0.502
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.498 0.502
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.498 0.502
E50.5 Vitamin A deficiency with night blindness
0.000 0.498 0.502
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.498 0.502
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.498 0.502
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.498 0.502
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.498 0.502
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.498 0.502
E51.9 Thiamine deficiency, unspecified
0.000 0.498 0.502
E51.8 Other manifestations of thiamine deficiency
0.000 0.498 0.502
E51.2 Wernicke's encephalopathy
0.000 0.498 0.502
E51.1 Beriberi
0.000 0.498 0.502
E56.9 Vitamin deficiency, unspecified
0.000 0.498 0.502
E56.8 Deficiency of other vitamins
0.000 0.498 0.502
E56.1 Deficiency of vitamin K
0.000 0.498 0.502
E56.0 Deficiency of vitamin E
0.000 0.498 0.502
E63.9 Nutritional deficiency, unspecified
0.000 0.498 0.502
E63.8 Other specified nutritional deficiencies
0.000 0.498 0.502
E63.1 Imbalance of constituents of food intake
0.000 0.498 0.502
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.498 0.502
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.498 0.502
E64.8 Sequelae of other nutritional deficiencies
0.000 0.498 0.502
E64.3 Sequelae of rickets
0.000 0.498 0.502
E64.2 Sequelae of vitamin C deficiency
0.000 0.498 0.502
E64.1 Sequelae of vitamin A deficiency
0.000 0.498 0.502
E64.0 Sequelae of protein-energy malnutrition
0.000 0.498 0.502
T45.5 Anticoagulants
0.491 0.509 0.000
E07 Other disorders of thyroid
0.000 0.510 0.490
E04.1 Non-toxic single thyroid nodule
0.000 0.523 0.477
E13.8 With unspecified complications
0.000 0.549 0.451
E13.7 With multiple complications
0.000 0.549 0.451
E13.6 With other specified complications
0.000 0.549 0.451
E13.5 With peripheral circulatory complications
0.000 0.549 0.451
E13.4 With neurological complications
0.000 0.549 0.451
E13.3 With ophthalmic complications
0.000 0.549 0.451
E13.2 With renal complications
0.000 0.549 0.451
E13.1 With ketoacidosis
0.000 0.549 0.451
E13.0 With coma
0.000 0.549 0.451
E14.3 With ophthalmic complications
0.000 0.566 0.434
E65-E68 Obesity and other hyperalimentation
0.000 0.589 0.411
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.608 0.392
E45 Retarded development following protein-energy malnutrition
0.000 0.608 0.392
E43 Unspecified severe protein-energy malnutrition
0.000 0.608 0.392
E42 Marasmic kwashiorkor
0.000 0.608 0.392
E41 Nutritional marasmus
0.000 0.608 0.392
E40 Kwashiorkor
0.000 0.608 0.392
E14.8 With unspecified complications
0.000 0.611 0.389
E14.7 With multiple complications
0.000 0.611 0.389
E14.6 With other specified complications
0.000 0.611 0.389
E14.5 With peripheral circulatory complications
0.000 0.611 0.389
E14.2 Withrenal complications
0.000 0.611 0.389
E14.1 With ketoacidosis
0.000 0.611 0.389
E14.0 With coma
0.000 0.611 0.389
K90 Intestinal malabsorption
0.000 0.627 0.372
E13.9 Without complications
0.000 0.634 0.365
E14.4 With neurological complications
0.000 0.643 0.357
E07.1 Dyshormogenetic goitre
0.000 0.648 0.351
E07.0 Hypersecretion of calcitonin
0.000 0.648 0.351
E04.2 Non-toxic multinodular goitre
0.000 0.677 0.323
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.316 0.683 0.001
E67 Other hyperalimentation
0.000 0.705 0.295
E68 Sequelae of hyperalimentation
0.000 0.705 0.295
E44.1 Mild protein-energy malnutrition
0.000 0.718 0.281
E44.0 Moderate protein-energy malnutrition
0.000 0.718 0.281
E07.9 Disorder of thyroid, unspecified
0.000 0.720 0.280
K90.9 Intestinal malabsorption, unspecified
0.000 0.727 0.273
L40-L45 Papulosquamous disorders
0.269 0.731 0.000
K90.3 Pancreatic steatorrhoea
0.000 0.733 0.267
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.733 0.267
K90.1 Tropical sprue
0.000 0.733 0.267
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.739 0.261
E65 Localised adiposity
0.000 0.750 0.250
E07.8 Other specified disorders of thyroid
0.001 0.751 0.249
K90.8 Other intestinal malabsorption
0.000 0.766 0.233
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.227 0.773 0.001
T40.8 Lysergide [LSD]
0.227 0.773 0.001
T40.7 Cannabis (derivatives)
0.227 0.773 0.001
T40.5 Cocaine
0.227 0.773 0.001
T40.3 Methadone
0.227 0.773 0.001
T40.1 Heroin
0.227 0.773 0.001
T40.0 Opium
0.227 0.773 0.001
E46 Unspecified protein-energy malnutrition
0.001 0.775 0.224
E67.8 Other specified hyperalimentation
0.000 0.788 0.211
E67.3 Hypervitaminosis D
0.000 0.788 0.211
E67.2 Megavitamin-B6 syndrome
0.000 0.788 0.211
E67.1 Hypercarotenaemia
0.000 0.788 0.211
E67.0 Hypervitaminosis A
0.000 0.788 0.211
L42 Pityriasis rosea
0.199 0.801 0.000
L44 Other papulosquamous disorders
0.193 0.807 0.000
L41 Parapsoriasis
0.193 0.807 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.193 0.807 0.000
T40.4 Other synthetic narcotics
0.184 0.816 0.001
T40.6 Other and unspecified narcotics
0.178 0.821 0.001
J33.0 Polyp of nasal cavity
0.000 0.825 0.175
E14.9 Without complications
0.000 0.840 0.160
J33 Nasal polyp
0.000 0.853 0.147
L41.9 Parapsoriasis, unspecified
0.138 0.861 0.000
L41.8 Other parapsoriasis
0.138 0.861 0.000
L41.5 Retiform parapsoriasis
0.138 0.861 0.000
L41.4 Large plaque parapsoriasis
0.138 0.861 0.000
L41.3 Small plaque parapsoriasis
0.138 0.861 0.000
L41.2 Lymphomatoid papulosis
0.138 0.861 0.000
L41.1 Pityriasis lichenoides chronica
0.138 0.861 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.138 0.861 0.000
L44.9 Papulosquamous disorder, unspecified
0.138 0.861 0.000
L44.8 Other specified papulosquamous disorders
0.138 0.861 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.138 0.861 0.000
L44.3 Lichen ruber moniliformis
0.138 0.861 0.000
L44.2 Lichen striatus
0.138 0.861 0.000
L44.1 Lichen nitidus
0.138 0.861 0.000
L44.0 Pityriasis rubra pilaris
0.138 0.861 0.000
J33.8 Other polyp of sinus
0.000 0.864 0.136
J33.9 Nasal polyp, unspecified
0.000 0.876 0.124
E20-E35 Disorders of other endocrine glands
0.000 0.878 0.122
Z80.0 Family history of malignant neoplasm of digestive organs
0.111 0.889 0.000
E66 Obesity
0.000 0.893 0.107
L43 Lichen planus
0.105 0.894 0.000
J33.1 Polypoid sinus degeneration
0.000 0.895 0.105
T40.2 Other opioids
0.103 0.897 0.001
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.088 0.912 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.912 0.087
E32 Diseases of thymus
0.000 0.912 0.087
E31 Polyglandular dysfunction
0.000 0.912 0.087
E30 Disorders of puberty, not elsewhere classified
0.000 0.912 0.087
E25 Adrenogenital disorders
0.000 0.912 0.087
E34 Other endocrine disorders
0.000 0.914 0.086
E22 Hyperfunction of pituitary gland
0.000 0.914 0.086
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.085 0.915 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.083 0.917 0.000
E20 Hypoparathyroidism
0.000 0.918 0.082
E24 Cushing's syndrome
0.000 0.918 0.081
E27 Other disorders of adrenal gland
0.000 0.919 0.081
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.081 0.919 0.000
E26 Hyperaldosteronism
0.000 0.921 0.079
E66.1 Drug-induced obesity
0.000 0.923 0.077
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.923 0.076
S32 Fracture of lumbar spine and pelvis
0.076 0.924 0.000
L43.3 Subacute (active) lichen planus
0.076 0.924 0.000
L43.2 Lichenoid drug reaction
0.076 0.924 0.000
L43.1 Bullous lichen planus
0.076 0.924 0.000
L43.0 Hypertrophic lichen planus
0.076 0.924 0.000
S31 Open wound of abdomen, lower back and pelvis
0.075 0.925 0.000
T91 Sequelae of injuries of neck and trunk
0.075 0.925 0.000
T90 Sequelae of injuries of head
0.072 0.928 0.000
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand
0.071 0.929 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.070 0.929 0.000
E28 Ovarian dysfunction
0.000 0.930 0.070
E22.1 Hyperprolactinaemia
0.000 0.930 0.070
T25 Burn and corrosion of ankle and foot
0.070 0.930 0.000
T21 Burn and corrosion of trunk
0.070 0.930 0.000
T15-T19 Effects of foreign body entering through natural orifice
0.070 0.930 0.000
Z80 Family history of malignant neoplasm
0.070 0.930 0.000
E27.1 Primary adrenocortical insufficiency
0.000 0.931 0.069
E29 Testicular dysfunction
0.000 0.931 0.069
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.931 0.069
T00-T07 Injuries involving multiple body regions
0.068 0.932 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.067 0.933 0.000
S36 Injury of intra-abdominal organs
0.067 0.933 0.000
E27.8 Other specified disorders of adrenal gland
0.000 0.933 0.067
E66.0 Obesity due to excess calories
0.000 0.934 0.066
T91.1 Sequelae of fracture of spine
0.066 0.934 0.000
S10-S19 Injuries to the neck
0.066 0.934 0.000
T98 Sequelae of other and unspecified effects of external causes
0.066 0.934 0.000
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand
0.065 0.935 0.000
S31.4 Open wound of vagina and vulva
0.065 0.935 0.000
S32.0 Fracture of lumbar vertebra
0.065 0.935 0.000
T91.9 Sequelae of unspecified injury of neck and trunk
0.064 0.936 0.000
T90.1 Sequelae of open wound of head
0.064 0.936 0.000
T90.8 Sequelae of other specified injuries of head
0.064 0.936 0.000
S39 Other and unspecified injuries of abdomen, lower back and pelvis
0.063 0.936 0.000
E34.8 Other specified endocrine disorders
0.000 0.937 0.063
T33-T35 Frostbite
0.063 0.937 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.063 0.937 0.000
E25.9 Adrenogenital disorder, unspecified
0.000 0.937 0.063
E25.8 Other adrenogenital disorders
0.000 0.937 0.063
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.937 0.063
E30.9 Disorder of puberty, unspecified
0.000 0.937 0.063
E30.8 Other disorders of puberty
0.000 0.937 0.063
E30.1 Precocious puberty
0.000 0.937 0.063
E30.0 Delayed puberty
0.000 0.937 0.063
E31.9 Polyglandular dysfunction, unspecified
0.000 0.937 0.063
E31.8 Other polyglandular dysfunction
0.000 0.937 0.063
E31.1 Polyglandular hyperfunction
0.000 0.937 0.063
E31.0 Autoimmune polyglandular failure
0.000 0.937 0.063
E32.9 Disease of thymus, unspecified
0.000 0.937 0.063
E32.8 Other diseases of thymus
0.000 0.937 0.063
E32.1 Abscess of thymus
0.000 0.937 0.063
E32.0 Persistent hyperplasia of thymus
0.000 0.937 0.063
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.937 0.063
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.937 0.063
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.937 0.063
E34.0 Carcinoid syndrome
0.000 0.937 0.063
T51 Toxic effect of alcohol
0.062 0.938 0.000
E34.5 Androgen resistance syndrome
0.000 0.938 0.062
E34.4 Constitutional tall stature
0.000 0.938 0.062
E34.3 Short stature, not elsewhere classified
0.000 0.938 0.062
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.938 0.062
E34.1 Other hypersecretion of intestinal hormones
0.000 0.938 0.062
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.938 0.062
E22.8 Other hyperfunction of pituitary gland
0.000 0.938 0.062
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.062 0.938 0.000
T20 Burn and corrosion of head and neck
0.062 0.938 0.000
S32.4 Fracture of acetabulum
0.061 0.939 0.000
T18 Foreign body in alimentary tract
0.061 0.939 0.000
S31.8 Open wound of other and unspecified parts of abdomen
0.061 0.939 0.000
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis
0.061 0.939 0.000
S37 Injury of urinary and pelvic organs
0.061 0.939 0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level
0.061 0.939 0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level
0.061 0.939 0.000
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis
0.061 0.939 0.000
Z80.6 Family history of leukaemia
0.061 0.939 0.000
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung
0.061 0.939 0.000
T91.3 Sequelae of injury of spinal cord
0.060 0.940 0.000
T21.2 Burn of second degree of trunk
0.060 0.940 0.000
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis
0.060 0.940 0.000
T25.0 Burn of unspecified degree of ankle and foot
0.060 0.940 0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot
0.059 0.941 0.000
L43.8 Other lichen planus
0.059 0.941 0.001
E20.8 Other hypoparathyroidism
0.000 0.941 0.059
E20.1 Pseudohypoparathyroidism
0.000 0.941 0.059
E20.0 Idiopathic hypoparathyroidism
0.000 0.941 0.059
E22.0 Acromegaly and pituitary gigantism
0.000 0.941 0.059
E24.8 Other Cushing's syndrome
0.000 0.941 0.058
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.941 0.058
E24.3 Ectopic ACTH syndrome
0.000 0.941 0.058
E24.1 Nelson's syndrome
0.000 0.941 0.058
S40-S49 Injuries to the shoulder and upper arm
0.059 0.941 0.000
E27.5 Adrenomedullary hyperfunction
0.000 0.942 0.058
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.942 0.058
E27.0 Other adrenocortical overactivity
0.000 0.942 0.058
E24.9 Cushing's syndrome, unspecified
0.000 0.942 0.058
T95 Sequelae of burns, corrosions and frostbite
0.058 0.942 0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source
0.058 0.942 0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances
0.058 0.942 0.000
S30 Superficial injury of abdomen, lower back and pelvis
0.058 0.942 0.000
Z80.4 Family history of malignant neoplasm of genital organs
0.058 0.942 0.000
E66.8 Other obesity
0.000 0.942 0.058
E34.9 Endocrine disorder, unspecified
0.000 0.942 0.057

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.